Content Management For Life Science Space Heats Up?
Recently Documentum announced a clear vertical product strategy to target the
Growing demand for targeted pharmaceutical products.
Arbortext, a global provider of XML-based software for multichannel publishing, workd is also focussing on the life sciences industry with new product capabilities and applications.
This initiative enables pharmaceutical companies, medical device manufacturers and biotechnology companies to bring new and revised products to market faster
while complying with complex regulatory requirements, ultimately avoiding costly penalties such as manufacturing delays, regulatory fines and missed revenue opportunities.
The new applications are a combination of Arbortext core products, partner integration and consulting services, says the company: Arbortext's Epic software provides the cornerstone for organizations to efficiently create, manage and publish complex business and technical documents, such as new drug applications, product information (package inserts, leaflets and labels), and written documentation of procedures that support the methods, facilities and controls used in the preparation, processing and packaging of pharmaceutical and medical products.
Some of the new product capabilities to support this initiative include:
· Change tracking
· Enhanced API including support for Active-X
· Stronger integration with Documentum's content management system
· Digital signatures and watermarks
Arbortext provides support for the following applications in life sciences:
· Pharmaceutical Manufacturing. With fines related to manufacturing process documentation reaching as high as $500 million, drug companies have a powerful incentive to automate the documentation process to reduce the risk of incomplete, incorrect or out-of-date information. Arbortext consolidates manufacturing documentation into a single source and process that eliminates redundancy and ensures that all information is consistent and comprehensive.
· Pharmaceutical Package Inserts and Labels.
Package inserts, leaflets and labels present a particular challenge to the
pharmaceutical industry as they must be modified for each form, dosage and
presentation of medication as well as be delivered in the native language of
the consumer. In Europe, it can take as many as 900 different documents to
support a single drug.
· Regulatory Submissions. Regulatory submissions consist of large amounts of complex information that must be assembled and submitted to the regulatory agencies of each country or region where the submitting company plans to market a product. For each day the product is delayed going to market, it can cost the manufacturer $1 million or more.
Customers in the life sciences industry Include Abbott Laboratories, American Medical Association, AstraZeneca, Beckman Coulter, Bristol-Myers Squibb, Canadian Pharmacists Association, GE Medical Systems, Guidant CPI, GlaxoSmithKline, Kimberly Clark, M&R Care Guidelines, Medtronic, Merck, MicroMedics, Novant Health, Pfizer, Pharmacopeia-Europe, Pharmacopeia-United States and Sanofi-Synthelabo.
Delicious
Digg
Reddit
Magnoliacom
Newsvine
Furl
Google
Yahoo
Technorati
Comments
Post new comment